Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vasodilators and Exercise as Adjuvant Therapy for Duchenne Muscular Dystrophy (VASO-REx Study)

NCT06290713 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT06290713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06290713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vasodilators and Exercise as Adjuvant Therapy for Duchenne Muscular Dystrophy (VASO-REx Study)
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Recruiting
Start date
June 5, 2024
Completion date
November 30, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dmd, duchenne disease, duchenne muscular dystrophy, exercise, muscular dystrophy, muscular dystrophy in children, vasodilation